Difference between revisions of "Improve Identification and Data Collection for NAS"
Jump to navigation
Jump to search
(Manual content copy/paste from prior wiki install; revision history not included) |
m (Mlabrie21 moved page Improve Identification & Data Collection for NAS to Improve Identification and Data Collection for NAS: Typo in title) |
(No difference)
| |
Revision as of 12:54, 14 January 2022
Return to ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use
Overview
One of the biggest challenges of addressing NAS is that it is not consistently identified, and collection of data and reporting is inconsistent.
Key Information
Relevant Research
Impactful Federal, State, and Local Policies
Indiana State Department of Health
In 2014, because of the high rate of opioid prescriptions, the Indiana General Assembly charged the Indiana State Department of Health (ISDH) to: develop a standard clinical definition of NAS and a standardized process of identifying it, identify the resources hospitals need to do this, and then establish a voluntary pilot program with hospitals to implement this standardized NAS identification. As of 2016, 26 of 89 Indiana Birthing Hospitals are taking part in this pilot screening program . ISDH noted that universal screening in a non-punitive environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.[1]
The Indiana State Department of Health (ISDH) established a Task Force which defined a standard clinical definition of Neonatal Abstinence Syndrome
- The infant must:
- Be symptomatic
- Have two or three consecutive modified Finnegan scores equal to or greater than a total of 24
- And have one of the following:
- A positive toxicology test OR
- A maternal history with a positive verbal screen or toxicology test
Available Tools and Resources
Sources
- [1]